Search by Drug Name or NDC
NDC 69238-2088-06 Bexarotene 10 mg/g Details
Bexarotene 10 mg/g
Bexarotene is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is BEXAROTENE.
MedlinePlus Drug Summary
Topical bexarotene is used to treat cutaneous T-cell lymphoma (CTCL, a type of skin cancer) that could not be treated with other medications. Bexarotene is in a class of medications called retinoids. It works by stopping the growth of cancer cells.
Related Packages: 69238-2088-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bexarotene Topical
Product Information
| NDC | 69238-2088 |
|---|---|
| Product ID | 69238-2088_e90bb84a-0b45-4163-92da-d8ed239a0b1d |
| Associated GPIs | 90376220004020 |
| GCN Sequence Number | 045771 |
| GCN Sequence Number Description | bexarotene GEL (GRAM) 1 % TOPICAL |
| HIC3 | Q5N |
| HIC3 Description | TOPICAL ANTINEOPLASTIC PREMALIGNANT LESION AGENTS |
| GCN | 89921 |
| HICL Sequence Number | 020832 |
| HICL Sequence Number Description | BEXAROTENE |
| Brand/Generic | Generic |
| Proprietary Name | Bexarotene |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bexarotene |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/g |
| Substance Name | BEXAROTENE |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215398 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69238-2088-06 (69238208806)
| NDC Package Code | 69238-2088-6 |
|---|---|
| Billing NDC | 69238208806 |
| Package | 1 TUBE in 1 CARTON (69238-2088-6) / 60 g in 1 TUBE |
| Marketing Start Date | 2022-05-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |